Andere Kunden interessierten sich auch für
![Androgen Receptor Expression and Gleason Scores in Prostate Cancer]( "Androgen Receptor Expression and Gleason Scores in Prostate Cancer")
Androgen Receptor Expression and Gleason Scores in Prostate Cancer35,99 €![Modulation of Cardiac Gene Expression Profiles]( "Modulation of Cardiac Gene Expression Profiles")
Modulation of Cardiac Gene Expression Profiles29,99 €![Determination of Changing Expression of miR-212 and EGFR Genes]( "Determination of Changing Expression of miR-212 and EGFR Genes")
Determination of Changing Expression of miR-212 and EGFR Genes29,99 €![Analysis of IMP3 expression in oral cancer]( "Analysis of IMP3 expression in oral cancer")
Analysis of IMP3 expression in oral cancer15,99 €![IGFBP-6 plays a role as an oncosuppressor gene in NPC pathogenesis through regulating EGR-1 expression]( "IGFBP-6 plays a role as an oncosuppressor gene in NPC pathogenesis through regulating EGR-1 expression")
IGFBP-6 plays a role as an oncosuppressor gene in NPC pathogenesis through regulating EGR-1 expression15,99 €![Gene Expression and Its Discontents]( "Gene Expression and Its Discontents")
Gene Expression and Its Discontents110,99 €![Success in Academic Surgery: Basic Science]( "Success in Academic Surgery: Basic Science")
Success in Academic Surgery: Basic Science37,99 €
Immunohistochemistry (IHC) is an ancillary method, widely used in pathologists' practice, that allows identifying diagnostic and prognostic/predictive of therapeutic response protein markers on tissue samples by the use of specific monoclonal antibodies and chromogenic substances that guarantee the visualization of an antibody-antigene binding complex under a light microscope [1]. Coon et al., in 1941 [2], first introduced the use of fluorochrome-conjugated antibodies in clinical practice. Since then, IHC has gone from being a useful tool for identifying the differentiation line of otherwise undifferentiated cells to a technique capable of providing not only diagnostic but also prognostic and predictive indications of responses to specific therapeutic options [1,3]. The abovementioned peculiarities have made IHC one of the most used ancillary methods in the histopathological approach to human neoplastic and non-neoplastic diseases [3-5]. This Special Issue contains 11 accepted papers that provide readers with a comprehensive update on current and future applications of IHC in medical practice.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.